实验方案(Protocols)

Recombinant Human GFRA2 Protein: Research Use Guidelines

Recombinant Human GFRA2 Protein is a research-grade recombinant co-receptor designed to support studies of GDNF family ligand signaling, neurturin binding, and RET kinase pathway activation in neuronal and non-neuronal model systems.

Product Name
Recombinant Human GFRA2 Protein
SKU
rp365087
Protein Family
GDNF Family Receptor Alpha (GFRα) co-receptor family
Primary Ligand
Neurturin (NRTN); also interacts with GDNF family members
Signaling Partner
RET receptor tyrosine kinase
Intended Use
Research use only (RUO); not for diagnostic or therapeutic use
Supplier Reference
absea#PP-626

Background and Biological Significance of GFRA2

GDNF Family Receptor Alpha 2 (GFRA2, also known as GFRα2 or RETL2) is a glycosylphosphatidylinositol (GPI)-anchored cell-surface co-receptor and a member of the GFRα family of proteins. It serves as the preferred high-affinity binding partner for neurturin (NRTN), a member of the glial cell line-derived neurotrophic factor (GDNF) family of ligands (GFLs).

Upon binding neurturin, GFRA2 recruits and activates the transmembrane receptor tyrosine kinase RET, initiating downstream signaling cascades including the MAPK, PI3K/AKT, and PLC-γ pathways. These signals regulate neuronal survival, differentiation, axonal growth, and synaptic plasticity, particularly in parasympathetic, enteric, and sensory neurons.

GFRA2 is expressed in multiple tissues during development and in the adult organism, including the nervous system and various peripheral organs. Research into GFRA2 biology has implications for understanding neurodegenerative conditions, enteric nervous system development, and pain perception pathways.

Product Handling and Storage Recommendations

To maintain the biological activity and structural integrity of Recombinant Human GFRA2 Protein, adherence to proper handling and storage protocols is essential. The following general best-practice guidelines apply to recombinant proteins of this class:

  • Upon receipt: Inspect the product and centrifuge briefly if liquid condensation is observed on the vial cap or sides before opening.
  • Reconstitution: If supplied in lyophilized form, reconstitute using sterile phosphate-buffered saline (PBS) or the buffer specified in the product datasheet. Allow the vial to equilibrate to room temperature before reconstitution to minimize aggregation.
  • Storage temperature: Store at −20 °C or −80 °C for long-term stability. Avoid repeated freeze-thaw cycles, which can reduce activity and promote aggregation.
  • Aliquoting: Prepare single-use aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles.
  • Working solutions: Dilute to the required working concentration in a carrier protein-containing buffer (e.g., 0.1% BSA in PBS) to stabilize the protein during experiments.

Note: Always refer to the specific product datasheet supplied with SKU rp365087 for lot-specific storage conditions, concentration, and expiry information.

Quality, Purity, and Regulatory Considerations

Recombinant Human GFRA2 Protein (rp365087) from Aladdin Scientific is manufactured to research-grade standards. Key quality considerations include:

  • Purity: Recombinant proteins in this class are typically verified by SDS-PAGE and/or HPLC analysis. Refer to the Certificate of Analysis (CoA) provided with each lot for confirmed purity data.
  • Endotoxin testing: Endotoxin levels should be assessed and minimized for cell-based assays. Consult the lot-specific CoA for endotoxin values.
  • Biological activity: Functional activity may be verified using cell-based bioassays measuring RET phosphorylation or neurite outgrowth in responsive cell lines. Refer to the datasheet for activity specifications.
  • Regulatory status: This product is supplied for research use only (RUO) and is not intended for human or veterinary diagnostic or therapeutic applications. It has not been evaluated by regulatory agencies for clinical use.
  • Lot-to-lot consistency: Contact Aladdin Scientific customer support for multi-lot qualification data if consistency across experiments is a critical requirement.

Frequently asked questions

What is the primary ligand for GFRA2, and how does it transduce signals?

The primary ligand for GFRA2 is neurturin (NRTN), a member of the GDNF family of ligands. Upon neurturin binding, the GFRA2–neurturin complex associates with the RET receptor tyrosine kinase, triggering RET autophosphorylation and activation of downstream pathways including MAPK, PI3K/AKT, and PLC-γ, which regulate neuronal survival, differentiation, and axonal growth.

How should I reconstitute and store Recombinant Human GFRA2 Protein to preserve its activity?

If supplied in lyophilized form, reconstitute the protein in sterile PBS or the buffer specified in the product datasheet, allowing the vial to equilibrate to room temperature first. Immediately aliquot reconstituted protein into single-use volumes and store at −20 °C or −80 °C. Avoid repeated freeze-thaw cycles, as these can reduce biological activity and cause aggregation. Always consult the lot-specific CoA for precise storage instructions.

Can Recombinant Human GFRA2 Protein be used as a decoy receptor to block neurturin signaling?

Yes, soluble recombinant GFRA2 lacking a membrane anchor can function as a competitive decoy receptor by sequestering neurturin and preventing it from engaging cell-surface GFRA2–RET complexes. This approach is widely used in research to dissect the specific contribution of the GFRA2–neurturin axis to cellular signaling. Optimal blocking concentrations should be empirically determined for each experimental system.

Is this product suitable for in vivo animal studies?

Recombinant Human GFRA2 Protein (rp365087) is designated for research use only and is primarily validated for in vitro applications. Its suitability for in vivo administration depends on lot-specific purity, endotoxin levels, and formulation. Researchers intending to use this product in animal studies should review the CoA and consult Aladdin Scientific technical support for guidance.

References

  1. Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nature Reviews Neuroscience. 2002;3(5):383-394. doi:10.1038/nrn812
  2. Baloh RH, Enomoto H, Johnson EM Jr, Milbrandt J. The GDNF family ligands and receptors - implications for neural development. Current Opinion in Neurobiology. 2000;10(1):103-110. doi:10.1016/s0959-4388(99)00048-3
  3. Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. Journal of Cell Science. 2003;116(Pt 19):3855-3862. doi:10.1242/jcs.00786

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human GFRA2 Protein: Research Use Guidelines》. 阿拉丁知识库,更新于 2026年10月31日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-gfra2-protein-research-use-guidelines-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助